Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Strategies for purging latently infected cells in HIV-positive patients studied at NIAID

Feb. 4, 1998

Promising efficacy reported at AIDS conference for amprenavir combinations

Feb. 3, 1998

Potent antiretroviral activity shown for abacavir + protease inhibitor in HIV-positive patients

Feb. 3, 1998

Swiss Remune trials initiated

Jan. 29, 1998

PMPA reduces viral load in phase I/II

Jan. 29, 1998

Triangle reports results from phase I/II FTC trial

Jan. 29, 1998

ACT evaluated in second phase I trial in HIV/AIDS patients

Jan. 28, 1998

New AIDS therapies in development in Korea

Jan. 28, 1998

Viracept approved for marketing in E.U. member countries

Jan. 23, 1998

Irreversible HIV protease inhibitors under evaluation at LG Chemical

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...